View Tesla (TSLA) as a long-term cornerstone investment in AI and robotics, with its primary value derived from future businesses like Robotaxi and Optimus. For a concentrated bet on the success of Bitcoin, consider MicroStrategy (MSTR) as a direct proxy and a hedge against the traditional financial system. Hims & Hers Health (HIMS) is presented as a current "bargain" for its potential to disrupt healthcare with its AI Doctor and pharmacy model that operates outside of insurance. These opportunities are high-conviction investments centered on the theme of AI-driven disruption across the transportation, finance, and healthcare sectors. Investors should approach these stocks with a long-term perspective, potentially holding beyond 2030 to realize their full potential.

Tesla (TSLA)

• The speaker presents Tesla not as a car company, but as a primary AI player. The majority of its valuation, in his view, comes from its potential as a Robotaxi company.
• The core vision is to disrupt the entire concept of transportation, with the goal of making Robotaxi services cost 20 cents per mile. This price point would disrupt car ownership, public transportation, and even short-haul train and plane trips.
• A major supporting trend is that Gen Z is getting driver's licenses at a lower rate, indicating a cultural shift away from personal car ownership.
• The speaker identifies several "side quests" that are massive businesses in their own right:
  • Energy Storage: The Megapack business is seen as a disruption to the electrical grid. The speaker notes that some in the Tesla community believe this business alone could justify Tesla's trillion-dollar valuation.
  • Charging Infrastructure: The Supercharger network is positioned to become the "Standard Oil of electricity," potentially replacing the entire gas station industry, which is described as highly leveraged and vulnerable.
  • Semi-Trucks: The Tesla Semi has the potential to disrupt the railroad industry.
  • Vertical Integration: Tesla captures more profit by owning the entire value chain, including manufacturing, software, repairs, used car sales, and forgoing the traditional dealership model.
• Artificial Intelligence (AI) is central to the thesis. Tesla develops its own hardware and software, similar to Apple, which allows for seamless integration. This AI capability is the foundation for the ultimate "wild card":
  • Optimus Robot: The speaker believes that even a 1% chance of success for the humanoid robot makes the stock cheap today. He argues these robots will be significantly better and faster than human labor, not just a replacement.

Takeaways

• Bullish Sentiment: The speaker is extremely bullish on TSLA as a long-term cornerstone investment, holding it beyond 2030.
• Valuation Perspective: Investors should view TSLA as an AI and robotics company, not just an automaker. The car business is considered a "side quest" compared to the potential of Robotaxi, Energy, and Optimus.
• Disruption Theme: The investment is a bet on the widespread disruption of multiple massive industries: transportation, energy, logistics, and labor.
• Ignore the "FUD": The speaker dismisses common criticisms (e.g., "self-driving will never happen") as "Fear, Uncertainty, and Doubt" (FUD) from people who misunderstand the company's progress and potential.

MicroStrategy (MSTR)

• MSTR is presented as a direct investment in the success of Bitcoin. The speaker states clearly: "If Bitcoin fails, MSTR is going to fail."
• The core thesis is that MSTR is using Bitcoin to "fix malinvestment" in the global financial system. It aims to disrupt the traditional debt market, which is seen as unstable because it's backed by unreliable appraisals (real estate) or fragile cash flows (jobs, corporate earnings) in a world being disrupted by AI.
• The speaker adamantly refutes the idea that MSTR is a "leverage play," stating its leverage is next to nothing (around 9%). He describes it as an "ATM story," meaning the company consistently sells its own stock to raise cash to buy more Bitcoin.
• MSTR is creating a new form of debt backed by a hard, transparent asset. An example given is their "Stretch" product, which was yielding 11% and is backed by Bitcoin on the balance sheet. This is contrasted with debt backed by the cash flows of a company like Netflix, which could be disrupted by AI.
• The long-term vision is that if Bitcoin becomes a globally respected currency on par with the USD or Euro, MSTR could become the largest financial firm in the world due to its significant holdings (marching towards 5% of the total supply).

Takeaways

• High-Risk, High-Reward Bitcoin Proxy: An investment in MSTR is a concentrated, high-conviction bet on the long-term success of Bitcoin. The risk of Bitcoin failing is explicitly accepted.
• Financial System Hedge: The thesis positions MSTR as a hedge against the current debt-based financial system, which the speaker believes is unsustainable in a deflationary, AI-driven world.
• Focus on the Mission: Investors should understand that MSTR is not just passively holding Bitcoin. It is actively building a financial services company that uses Bitcoin as its foundation to offer new types of financial products.
• Bearish Short-Term, Bullish Long-Term: The speaker acknowledges the poor performance in 2025 was tied to Bitcoin's price but believes money will flow back into the space. The investment is framed with a multi-decade timeline.

Hims & Hers Health (HIMS)

• HIMS is described as a "zero-to-one" company applying tech principles to disrupt the traditional "sick care" system and create true "health care."
• The company's key advantage is that it operates outside the health insurance system. The speaker argues the insurance model is fundamentally flawed because it requires prices to rise, moves too slowly for an innovative company, and stifles new procedures.
• HIMS is positioned as an AI Doctor and AI Pharmacy. Its core innovations include:
  • Collapsing Costs: The doctor's visit is included in the price of the drug. Since AI makes knowledge nearly free, the cost of care should collapse to the cost of the pill itself.
  • AI-Powered Recommendations: HIMS uses a recommender system called MedMatch, which is fed by data from over 2 million patients, to match individuals with the most effective therapies.
  • Mass Customization: The company can create customized pills with specific dosages (e.g., a 637mg pill) and ingredients tailored to an individual, moving beyond the one-size-fits-all model of traditional pharmaceuticals.
  • Data Acquisition: HIMS offers comprehensive lab testing for $199 (a service that would allegedly cost tens of thousands of dollars otherwise) to gather more data for its AI. The eventual goal is to make this testing free to create an unparalleled dataset for preventative care.
• The future vision includes integrating with smartwatches and creating "digital twins" of patients to simulate the effects of a drug before it's ever taken.

Takeaways

• Bullish Sentiment: The speaker is extremely bullish, calling the stock a "bargain" and a "steal."
• Disruption of Healthcare: This is an investment in the disruption of the entire healthcare value chain: insurance companies, doctor gatekeepers, physical pharmacies, and pharmaceutical manufacturing.
• AI and Data Play: The core of the investment thesis is the company's powerful data flywheel. By offering low-cost services, it gathers massive amounts of patient data, which makes its AI smarter, which in turn improves its products and attracts more customers.
• Focus on Prevention: HIMS is not trying to compete in "sick care" (treating established, serious diseases). It is creating a new market for "health care" (preventative, proactive care for healthy people to address issues early).